MEDICAL BUSINESS
To a defiant Joe Biden, the 2024 race is up to the voters, not to Democrats on Capitol Hill
On Saturday, a fifth Democratic lawmaker said openly that Biden should not run again. Rep. Angie Craig of Minnesota said that after what she saw and heard in the debate with Republican rival Donald Trump, and Biden's "lack of a forceful response" afterward, he should step aside "and allow for a new generation of leaders to step forward."
Joe Biden's latest health concern: Reports of Parkinson's disease specialist visiting White House surfaces
Joe Biden is yet again amid a massive health scare scenario after top Parkinson's disease specialist in the country visited the White House to meet Joe Biden's physician along with two other doctors, according to latest reports. How will this reflect with US voters ahead of the Presidential Elections?
Business first, stock second: 5 largecap stocks where management & business are better placed with an upside potential of upto 23%
What does a hospital, chemical or rather specialty gas supplier, FMCG, and real estate company have in common? Surely not the product. What binds them is the ability of management which has been tested in tough times. Another common factor, business is such that returns on investment are higher and are also consistent. The reason why these things become important at this point of time is the fact that in bull markets, there is no dearth of explanation and narrative, when putting money one has to look at one reason which becomes the focal point to avoid panic when there is correction. So, if the management and business are good then corrections will come and go and in the long term higher return would compensate for the patience which one shows in the times of correction.
Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%
The bullish mode and mood of the market, which is already in place on the street as the nifty touched new high, is likely to get a boost as the first indication of return of FPI comes to markets. The budget and the narrative which gets built post that is going to play an important role in that. Maintaining fiscal discipline and announcing continuing policy push for key sectors would be key for that. We look at stocks which have witnessed a continuous rise in their score in the last one month. These selected stocks depict a strong upward trajectory in their overall average score which is based on five key pillars i.e. earnings, fundamentals, relative valuation, risk and price momentum. This implies that there has been a significant improvement in their market outlook in the given time frame.
Summers are over. Should a tactical trade turn into a long-term investment? 5 AC & white goods stocks which surged with the rising temperature
There are many sectors which make it to headlines at a particular time of the year. Like we would see agriculture and irrigation stock coming to headline around budget time, hotel stocks during holiday season. So, while they are cyclical stocks, because their cycles are much shorter as compared to typical cyclical stocks like metals, where cycles may last for many years, they are not typically classified as cyclical stocks. But essentially they are and cyclical stocks are more tactical trade rather than long term investment, which you can buy and forget for years. There is another set of companies who also make it to the headline and probably to the list of top gainers around the same time every year. Companies whose fortunes are linked with what happens in the summer season. This time again it happened, right from AC makers to fan makers to an ice cream company. All have witnessed an upward movement. Should be kept for it is time to say goodbye till next season.
21-year-old Keralite splurges Rs 10 lakh on new car! Meet IAS aspirant who also runs a thriving coaching business
His YouTube channel, IAS Hub Malayalam, has attracted 2.1K subscribers. His audience comprises clerks, college teachers, IT professionals, chemical engineers, homemakers, and fellow college students. Chako was the only teacher aware of his side venture.
- Go To Page 1
Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 25%
Every now and then the nifty keeps witnessing volatile movement, the difference this week was amidst all the intraday volatility because the bias of volatility has changed, nifty was able to touch a new high. Also because market breadth was positive, the trend for the majority would be bullish. Given the fact that macros are shaping for good, it appears that there is no reason for bulls to leave their control any time soon. While being bullish, be ready for a phase of volatility. In such times, if one is taking fresh exposure to equity, ensure that there is some level of quality as far as the business and fundamentals are concerned. These selected stocks depict a strong upward trajectory in their overall average score which is based on five key pillars i.e. earnings, fundamentals, relative valuation, risk and price momentum. This implies that there has been a significant improvement in their market outlook in the given time frame.
Only 3% of India’s 62 million business owners have SME insurance: ICICI Lombard’s Anand Singhi
Our focus on end-to-end risk management for MSMEs through various tailored digital solutions makes us different, says Anand Singhi, Chief of Retail and Government Business at ICICI Lombard.
As tech grip on medical industry becomes stronger, it creates space for new jobs profiles
Ebenazer Paul highlights the increasing demand for skilled professionals in medical billing and coding, driven by technological advancements and evolving healthcare regulations. The industry offers diverse opportunities for growth and specialization, with a focus on continuous education and certifications to stay competitive.
Is your medical claim stuck? Find out why you face problems in health insurance claim settlement and how to avoid them
While health insurers can sometimes be blamed putting customers through unending hardship in clearing claims, many a times it’s the policyholder who is at fault. A significant portion of these health insurance claim rejections can be prevented by asking the right questions during policy selection, carefully reviewing policy documents, and conducting thorough research. This article explores common health insurance claim rejection scenarios and explains how to avoid them.
Everstone to merge two healthcare companies, list combined firm
Everstone Capital, a Pan Asia private equity fund, is merging Translumina Therapeutics, a major cardiac stent maker in India, as part of a big-ticket IPO plan.
Fresh hurdles for Mike Tyson ahead of his bout with Jake Paul
The Boxing legend will have to undergo rigorous health check-ups after a medical issue. The fight could also be called off if he fails in any of these tests.
Sun Pharma-Moebius Medical anti-osteoarthritis injection shows sustained pain relief in clinical trials
Sun Pharma and Moebius Medical announced that their intra-articular injection MM-II showed greater pain relief than placebo for up to 26 weeks in osteoarthritis (OA) patients, based on clinical trial data. The study demonstrated that from weeks 12 to 26, more patients on MM-II experienced significant pain improvement compared to those on placebo. MM-II, a novel non-opioid, uses a proprietary suspension of liposomes to reduce joint friction and pain. The companies plan to initiate a Phase 3 clinical program and seek a CE Mark for the product in the European Union.
Japanese meditech Olympus Corporation to establish R&D and offshore development centre in Hyderabad
Olympus currently has R&D centers in Japan, US and Europe and is planning to leverage Indian local talent and resources to drive advancement in Indian medical technology. The decision follows a strategic agreement with HCL Tech, aimed at expanding Olympus' innovation generation activities globally. Olmpus makes medical devices such as endoscopy, imaging systems, surgical instruments.
Ayushman coverage to all over 70 years, roll out of U-WIN in health ministry's 100-day agenda
The new government under Narendra Modi aims to extend Ayushman Bharat coverage to individuals above 70 years and implement the pan-India roll out of the U-WIN portal for digitizing routine vaccinations as part of the 100-day agenda for the Union health ministry.
AAP, Congress slam Centre over irregularities in NEET exam, demand investigation
Taking to X, AAP shared a video that described the NEET exam scam, "The National Testing Agency (NTA) released the scorecard of NEET UG results on June 4- the same day the counting of votes for the Lok Sabha was held. A total of 67 students secured rank 1 in the exam. Six students, among the candidates who achieved rank 1, have taken the exam at the same centre. Many students secured 720 out of 720 or 718 or 719 out of 720. The government that cannot able to conduct examinations transparently is corrupt."
Capital-in-waiting? Election results ignite real estate frenzy in Amaravati, prices soar 50%-100% in 3 days
The 2024 Indian elections brought more than political shifts, with Amaravati witnessing a staggering 50%-100% surge in real estate prices within days of the results, according to The Times of India. The victory of the TDP, Jana Sena, and BJP alliance resolved uncertainties about the capital, reigniting buyer interest. All eyes are on Prime Minister Narendra Modi's anticipated statement during N Chandrababu Naidu's upcoming swearing-in ceremony as CM on June 12 near AIIMS in the capital region.
Canon in talks with Indian, global players to supply chip making machine
Canon is exploring partnerships with Indian and global players for semiconductor lithography equipment essential in chip fabrication, aiming to challenge ASML. The company is in talks with semiconductor firms investing in India, including Tata Group and PSMC. Canon also launched Canon Medical Systems India to meet the rising demand for medical equipment, targeting key markets like Chennai, Hyderabad, and Mumbai.
Pill for China plus one
Indian pharma CEOs met senior officials in FDA and other key agencies to start a conversation. Even if a little late, given the looming presidential election, the proposal deserves attention. The basic idea is to capitalise on India's expertise and infra for manufacturing through financial incentives, tech sharing, collaborative research and tech transfers to expand production in both countries. Pursue onshoring in America and friendshoring in India to reduce dependence on China. And aggregate US, Indian and European demand for certain drugs, as IPA secretary general Sudarshan Jain told me.
BharatX expands into healthcare finance with acquisition of Zenifi
Fintech startup BharatX acquires healthcare finance firm Zenifi to enter medical lending. Zenifi CEO Padam Kataria joins BharatX to lead healthcare lending vertical.
India needs a robust system to protect doctors from bogus lawsuits & ensure accountability for negligence
Indian Medical Association (IMA) praised GoI for criminal reforms absolving medical fraternity from liability under Section 304(a) of IPC, now Section 26 of Bharatiya Nyaya Sanhita. Supreme Court's 'Jacob Mathew vs State of Punjab' judgment balanced protecting doctors from frivolous prosecutions and accountability in negligence cases. Medical Council of India enforces ethical standards for doctors.
Larsen & Toubro bags multiple orders for buildings, factories business
Larsen & Toubro's buildings and factories business secures a project from Institute of Neurosciences Kolkata to build a medical college and hospital campus in Kolkata. The project, spanning 60 months, includes a 605-bed hospital and a medical college with civil structure and external development works.
Cipla ups investment in point-of-care testing firm Achira Labs
Cipla has announced further investment of up to Rs 26 crore in Achira Labs, a company specializing in point-of-care medical test kits. This investment will be made in four tranches, contingent upon the achievement of specific milestones. After the first tranche, Cipla will hold 27.27% of the total voting rights in Achira. This decision follows Cipla's initial acquisition of a 21.05% stake in Achira Labs in June 2022. Achira Labs, based in Bengaluru, focuses on developing and commercializing regulatory-approved medical diagnostic products using microfluidic technology.
Umesh Pagariya, Director of Pagaria Group, pioneers family legacy with his business acumen
Umesh Pagariya, torchbearer of Pagariya Group, upholds family traditions with visionary innovation in Jalgaon, rooted in Marwari heritage. Strategic acquisitions and ventures in safety equipment and FMCG lead to global expansion.
Kotak Alt to invest Rs 400 crore in medical device maker Biorad Medisys
Kotak Strategic Situations India Fund II (KSSF II) managed by Kotak Alternate Asset Managers Limited (Kotak Alt) announced investing up to Rs 400 crore in medical device manufacturer Biorad Medisys. The investment will primarily facilitate a new manufacturing plant setup, debt repayment, and increased working capital.
Razorpay revamps health insurance policy, provides coverage for vital medical treatments
Razorpay unveils new employee health insurance policy covering vital treatments like HIV/AIDS and conditions such as polycystic ovary syndrome. Employees can customize plans to include siblings, LGBTQIA+ partners, and enhanced maternity benefits. The move aligns with the trend of personalized, comprehensive healthcare offerings in India.
M3M to lease 1.5 million sq ft of commercial space in 2024-25
Company’s one-million square feet, International Financial Centre (IFC) at Golfcourse Extension Road is already 100% occupied while 700,000 square feet office space project, Urbana Business Park (UBP), is also has 75% occupancy.
Health insurance premium shot up over 25% last year for 52% policyholders, finds survey; here's how the impact can be reduced
Health insurance: Premiums of health insurance policies went up by more than 25% for 52% policyholders in India over the last 12 months. In this article we tell you how this will impact senior citizens and others and how you can take steps to reduce its impact if you are a new health insurance policy buyer.
India reverses old trend in medical consumables business, is now a net exporter
Till now, foreign-sourced goods used to dominate the medical consumables and disposables market in the country. In the fiscal year 2022-23, India was finally able to reverse that old trend, having sold more than it bought.
Load More
